Exploring the Role of iPSC-Cardiomyocytes in Drug Discovery and Safety Assessment
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are increasingly utilized in drug discovery, safety assessment of pharmaceutical compounds, and studies of disease mechanisms. The opportunity to measure the contractility, viability, and electrophysiology of these cells in real time over extended periods provides researchers with additional mechanistic insights into the roles cardiomyocytes play in both normal development and cardiac disease, in addition to providing incisive information regarding drug efficacy and toxicity.
In this special webinar, scientists using hiPSC-CMs will describe novel approaches for further enhancement of hiPSC-CM functionality, enabling assessment of compounds that modulate the force of contraction in addition to examining the impact of drugs and drug combinations on cardiac safety and efficacy.
Event Date: 2017-09-07 To 2017-09-07